Arrowhead Research Corporation vs Johnson & Johnson
ARWR vs JNJ — side-by-side comparison from reported financials. ARWR leads 4, JNJ leads 5 of 9 comparable metrics.
Arrowhead Research Corporation
ARWR · Healthcare
$62.75+3.31%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ARWR | JNJ |
|---|---|---|
| Price | $62.75 | $261.79 |
| Market cap | $8.86B | $631B |
| Revenue (TTM) | $669M | $97.9B |
| Revenue growth | +50.5% | +5.6% |
| Net margin | -47.8% | 21.5% |
| Free cash flow | -$75.1M | $22.2B |
| Net cash (debt) | $478M | ($27.8B) |
| 1-year price return | +74.0% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | 85% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -61% | 26% |
| Altman Z-score | 2.52 | — |
| CV checks passed | 5 of 9 | 10 of 9 |
| Employees | 711 | 140,800 |
Full résumé-style profiles: ARWR CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.